• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join Us
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page
Pharmabiotics 2023 | “The Future of Microbiome-based Medicinal Products”

Pharmabiotics 2023 | “The Future of Microbiome-based Medicinal Products”

by PRI | Feb 23, 2023 | News & Events

The PRI is pleased to host the 8th annual 2023 Pharmabiotics Conference & Partnering Event – returning to Lyon, France, at the Espace Tete d’Or Conference Center.   We are particularly proud of our program content this year, as we have continued...
Exploring the proposed regulation on SoHO (Céline Druart, London Feb. 2023)

Exploring the proposed regulation on SoHO (Céline Druart, London Feb. 2023)

by PRI | Jan 30, 2023 | News & Events

This week PRI Microbiome Project Manager Céline Druart (PhD) will speak at Hanson Wade’s Microbiome Movement Drug Development Europe event. Her presentation is titled, “Exploring the EU Proposal for a new SoHO Regulation and the Impact on Microbiome-based...
EDQM Publishes Guide on Quality of Tissues and Cells – 5th Edition

EDQM Publishes Guide on Quality of Tissues and Cells – 5th Edition

by PRI | Jan 17, 2023 | News & Events

The EDQM (European Directorate for the Quality of Medicines & Healthcare) has released the 5th version of the Guide to the quality and safety of tissues and cells for human application on 15 December 2022. This updated version results from an extensive revision...
PRI Board elects new President Sandrine Claus, Executive Committee

PRI Board elects new President Sandrine Claus, Executive Committee

by PRI | Jan 16, 2023 | News & Events

The PRI is pleased to announce Dr. Sandrine Claus has been elected Association President (effective 9 January 2023). As President, Sandrine will lead the Executive Committee and Board of Directors within the Association. Since the last update to the PRI Bylaws (Dec...
Hospital-ASST Bergamo Est

Hospital-ASST Bergamo Est

by PRI | Dec 6, 2022 | Microbiome Research & Technology (public)

Fabio Pace (MD) GI Unit Director ASST Bergamo Est Hospital Lombardy region, Italy...
« Older Entries
Next Entries »

Recent News & Events

  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)
  • 2024 Pharmabiotics Conference & Partnering – Lille
  • Céline Druart appointed PRI Executive Director following Magali Cordaillat-Simmons’ decision to step down

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Non-Profit Association (loi 1901) – 1 bis, rue Sénateur Emile Roux, 11100 Narbonne, France

Agence de communication : Frelonbleu